FIELD: chemistry.
SUBSTANCE: described are novel compounds of series 2-propen-1-on of general formula 
or their tautomeric forms, stereoisomers, polymorphs, pharmaceutically acceptable salts, pharmaceutically acceptable solvates, where Q stands for heteroaryl cycle, containing up to 2 nitrogen atoms. Compounds I induce HSP-70 and are useful in treatment of diseases accompanying pathologic process in organisms of mammals, including humans.
EFFECT: novel compounds possess useful biological properties.
26 cl, 7 tbl, 179 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PIPERIDINYL COMPOUNDS FOR SELECTIVE INTEGRINE BINDING | 2003 |
|
RU2333210C2 |
| BENZENE OR THIOPHEN DERIVATIVE AND USING IT AS VAP-1 INHIBITOR | 2009 |
|
RU2526256C2 |
| PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS | 2006 |
|
RU2420519C2 |
| INDOLE COMPOUNDS AS CELL NECROSIS INHIBITORS | 2008 |
|
RU2477282C2 |
| NEW COMPOUNDS AND COMPOSITIONS FOR CATHEPSIN INHIBITION | 2004 |
|
RU2346943C2 |
| PYRIDO[3,4-D]PYRIMIDINE DERIVATIVE AND ITS PHARMACEUTICALLY ACCEPTABLE SALT | 2017 |
|
RU2796400C2 |
| ARYLCARBONYL DERIVATIVES AS THERAPEUTIC AGENTS | 2003 |
|
RU2340605C2 |
| NEW HYDROXAMIC ACID DERIVATIVE | 2011 |
|
RU2575129C2 |
| INDOLE AND INDAZOLE COMPOUNDS AS CELLULAR NECROSIS INHIBITORS | 2008 |
|
RU2437883C1 |
| BENZYLAMINE DERIVATIVES | 2014 |
|
RU2660421C2 |
